SCHEMBL4899783

SCHEMBL4899783

CCN(Sc1ccc(Oc2ccc(OC(F)(F)F)cc2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PKM P14618 1/20 0.40
HCRTR2 O43614 1/20 0.38
MMP9 P14780 6/20 0.38
MMP2 P08253 5/20 0.38
TSHR P16473 1/20 0.37
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
MMP1 P03956 2/20 0.36
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
NR3C1 P04150 1/20 0.34
MMP3 P08254 1/20 0.34
MMP7 P09237 1/20 0.34
MMP8 P22894 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907051 0.97 ALDH1A1 (0.41) ALDH1A1KDM4EPKMHCRTR2TSHR
SCHEMBL4902550 0.93 TRPM8 (0.38) ALDH1A1KDM4EPKMHCRTR2MMP9
SCHEMBL4899562 0.92 ALDH1A1 (0.36) ALDH1A1MMP9MMP2TSHRLMNA
SCHEMBL4905600 0.90 ALDH1A1 (0.38) ALDH1A1KDM4EPKMMMP9MMP2
SCHEMBL4902983 0.90 ALDH1A1 (0.39) ALDH1A1KDM4EMMP9MMP2TSHR
SCHEMBL4904210 0.90 KDM4E (0.40) ALDH1A1KDM4EMMP9TSHRLMNA
SCHEMBL4906561 0.90 ALDH1A1 (0.44) ALDH1A1KDM4EPKMHCRTR2MMP9
SCHEMBL4895549 0.89 ALDH1A1 (0.39) ALDH1A1KDM4EMMP9MMP2TSHR
SCHEMBL4905350 0.89 TRPM8 (0.40) ALDH1A1KDM4EPKMHCRTR2PPARD
SCHEMBL4902601 0.89 ALDH1A1 (0.38) ALDH1A1KDM4EPKMMMP9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885KDM4E 3750/4885PKM 896/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885KDM4E 3834/4885PKM 861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.